Who Paid My Doc
Augment Injectable
Device Bone Substitutes
PDI 10859477002140
General payments
$4,329,024
Research payments
$20,640
Through program year 2025, $4,329,024 in general payments and $20,640 in research payments were reported against Augment Injectable (Bone Substitutes).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,575,145 | 6,872 |
| 2024 | General | $1,279,154 | 5,646 |
| 2024 | Research | $5,201 | 2 |
| 2023 | General | $603,437 | 5,909 |
| 2023 | Research | $5,500 | 2 |
| 2022 | General | $523,972 | 4,090 |
| 2021 | General | $347,316 | 2,376 |
| 2021 | Research | $9,939 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
24,893 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.